PPAR-δ/β Overexpression Increases Colon Tumorigenesis

Get Permission

Although it is known that nuclear receptor peroxisome proliferator-activated receptor-δ/β (PPAR-d) is upregulated in colorectal cancer, the role of PPAR-d in tumorigenesis remains uncertain. In a study reported in Journal of the National Cancer Institute, Zuo and colleagues developed a mouse model of intestinally targeted PPAR-d overexpression to simulate PPAR-d upregulation in human colon cancer. Mice with and without targeted PPAR-d overexpression were tested for azoxymethane-induced colonic tumorigenesis.

It was found that targeted PPAR-d overexpression increased colon tumor incidence from 0 of 10 wild-type littermate mice to 9 of 10 mice in PPAR-d-1 and PPAR-d-2 mouse lines and tumor number from 0.47 in wild-type littermates to 2.15 in PPAR-d-1 mice and from 0.44 in wild-type littermates to 1.91 in PPAR-d-2 mice.

PPAR-d overexpression reversed resistance to azoxymethane-induced colon tumorigenesis in C57BL/6 mice. Further, PPAR-d overexpression modulated the expression of a number of novel PPAR-d target genes in normal-appearing mouse colon epithelial cells in a pattern that matched changes in colon tumors.

The investigators concluded, “Our finding that PPAR-d upregulation profoundly enhances susceptibility to colonic tumorigenesis should impact the development of strategies of molecularly targeting PPAR-d in cancer and noncancerous diseases.” ■

Zuo X, et al: J Natl Cancer Inst 106(4):dju052, 2014.




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.